High blood levels of asymmetric dimethylarginine (ADMA) are associated with future development of adverse cardiovascular events.
None of the baseline variables predicted a favorable response to BoNT-A treatment or the development of adverse effects.
In our study, CADO was unable to significantly protect the heart from the development of adverse LV remodelling, as assessed by LV volumes and EF.
Due to the complexity and characteristics of their patients, neonatal units are risk areas for the development of adverse events (AE).
The presence of β-adrenoreceptors in cardiac and vascular tissue leads to the possibility of the development of adverse cardiovascular events.
This creates a drug-drug interaction (DDI) network, which is one of the commonest cause of the development of Adverse Events (AEs) and reduction of clinical efficacy of the administered drugs.
In particular, the literature review considered the following PICO: P (patients undergoing spinal surgical procedure), I (surgical disposable instrument kit), C (surgical reusable instrument kit), O (outcome related to the development of adverse events, economic data and clinical effectiveness).
A variety of standards and guidelines for exposure to fluoride have been recommended to aid in the protection against dental caries and/or the development of adverse health effects.
A nonsedating, nonimpairing (even at higher than recommended doses), second-generation antihistamine is preferred for all patients, particularly those with a higher risk for the development of adverse effects.
However, in conjunction with the progression of the disease, long-term L-DOPA treatment leads to the development of adverse responses including debilitating L-DOPA-induced dyskinesias (LIDs) that can include choreic, hyperkinetic movements or dystonic movements [1], [2], [3].
All these conditions facilitate the development of adverse events (AEs).
